Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron

In this study, we evaluated the efficacy of a heterologous three-dose vaccination schedule against the Omicron BA.1 SARS-CoV-2 variant infection using a mouse intranasal challenge model. The vaccination schedules tested in this study consisted of a primary series of 2 doses covered by two commercial...

Descripción completa

Detalles Bibliográficos
Autores principales: Bottero, Daniela, Rudi, Erika, Martin Aispuro, Pablo, Zurita, Eugenia, Gaillard, Emilia, Gonzalez Lopez Ledesma, Maria M., Malito, Juan, Stuible, Matthew, Ambrosis, Nicolas, Durocher, Yves, Gamarnik, Andrea V., Wigdorovitz, Andrés, Hozbor, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667599/
https://www.ncbi.nlm.nih.gov/pubmed/38022542
http://dx.doi.org/10.3389/fimmu.2023.1271209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667599/
https://www.ncbi.nlm.nih.gov/pubmed/38022542
http://dx.doi.org/10.3389/fimmu.2023.1271209

Ejemplares similares